Varenicline Tablet, Film Coated
Product Images NDC 72603-477

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 72603-477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vareniclinefigure1 (Vareniclinefigure1)

A bar graph comparing the percentage outcomes across five different studies involving Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible dosage, Bupropion SR 150 mg BID, and placebo. The y-axis shows percentage values from 0% to 60%. Each study group is labeled along the x-axis with bars representing the different treatments and placebo outcomes, including error bars indicating variability or confidence intervals.*

FDA Label Image

Vareniclinefigure2 (Vareniclinefigure2)

A bar chart comparing percentage data across five studies involving Varenicline in various dosages and combinations. The x-axis lists treatment groups including Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible, Varenicline 1.0 mg plus Bupropion SR 150 mg BID, Bupropion SR 150 mg BID alone, and Placebo. The y-axis represents percentage values up to 35%. Each study group shows multiple bars with error bars indicating variability.*

FDA Label Image

Vareniclinefigure3 (Vareniclinefigure3)

A line graph showing the percentage of continuous abstinent individuals over nontreatment follow-up weeks. It compares Varenicline 1.0 mg BID and placebo groups, with abstinence percentages declining over time for both.*

FDA Label Image

Vareniclinestructure (Vareniclinestructure)

Chemical structure of varenicline tartrate, the active ingredient in Varenicline tablets. The diagram shows the molecular arrangement of the varenicline and tartrate components.*

FDA Label Image

Vareniclinetab05mgand1mgblistercard (Vareniclinetab05mgand1mgblistercard)

Packaging label for Varenicline Tablets Starting Pack by NorthStar RxLLC. The label describes a blister pack system with multiple weeks of tablets, including a green starting week blister card and blue continuing weeks blister cards. Dosages indicated are 0.5 mg and 1 mg film-coated oral tablets, with a total of 11 tablets at 0.5 mg and 42 tablets at 1 mg. The label includes instructions to use the starting week blister first and other medication guidance information.*

FDA Label Image

Vareniclinetab05mgand1mgmonthbox (Vareniclinetab05mgand1mgmonthbox)

Packaging label for Varenicline Tablets Starting Month Box by NorthStar Rx LLC. The box contains a 4-week supply with 0.5 mg tablets for the first week and 1 mg tablets for the following three weeks. Tablets are film-coated for oral use. The label includes NDC 72603-478-01, directions for use, manufacturer details (Hetero Labs Limited, India), and storage instructions.*

FDA Label Image

Vareniclinetab05mglabel (Vareniclinetab05mglabel)

Label for Varenicline Tablets 0.5 mg film-coated tablets by NorthStar Rx LLC. The label states each tablet contains 0.855 mg varenicline tartrate equivalent to 0.5 mg varenicline free base. Package contains 56 tablets. Storage instructions, manufacturer details (Hetero Labs Limited, India), and pharmacist dispensing note are included. Barcode and lot information are visible.*

FDA Label Image

Vareniclinetab1mglabel (Vareniclinetab1mglabel)

Varenicline Tablets 1 mg film-coated oral tablets label. The label states 56 tablets per container. It includes dosage information, storage instructions, and manufacturer details from NorthStar Rx LLC, Memphis, TN, and Hetero Labs Limited, India. The label features an NDC number and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.